Page last updated: 2024-09-03

gefitinib and Blood Pressure, High

gefitinib has been researched along with Blood Pressure, High in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Fan, G; Li, Q; Liu, G; Liu, X; Lu, J; Shen, X; Wang, F; Wang, S; Zhu, H; Zhu, Y1
Abulimiti, B; Dong, X; Fu, Z; Jin, M; Maimaitituersun, G1
Chadjichristos, C; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Guerrot, D; Helle, F; Jouzel, C; Placier, S1
Chansel, D; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Placier, S; Tharaux, PL1

Other Studies

4 other study(ies) available for gefitinib and Blood Pressure, High

ArticleYear
Severe adverse cutaneous reactions induced by gefitinib combined with antihypertensive and antihyperlipidemic drugs in lung cancer: a case report.
    Anti-cancer drugs, 2022, 01-01, Volume: 33, Issue:1

    Topics: Adenocarcinoma of Lung; Antihypertensive Agents; Antineoplastic Agents; Cytochrome P-450 CYP3A; Drug Eruptions; Female; Gefitinib; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lung Neoplasms; Lymphatic Metastasis; Middle Aged

2022
Gefitinib Increases the Incidence of QT Prolongation in Patients with Non-Small Cell Lung Cancer.
    International heart journal, 2023, Volume: 64, Issue:3

    Topics: Carcinoma, Non-Small-Cell Lung; Electrocardiography; Gefitinib; Humans; Hypertension; Incidence; Long QT Syndrome; Lung Neoplasms

2023
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
    American journal of physiology. Renal physiology, 2009, Volume: 297, Issue:1

    Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction

2009
Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2004, Volume: 18, Issue:7

    Topics: Animals; Capillaries; Collagen; Collagen Type I; Creatinine; Endothelin-1; ErbB Receptors; Fibrosis; Gefitinib; Gene Expression Regulation; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Hypertension; Ischemia; Kidney; Kidney Cortex; Kidney Diseases; Kidney Glomerulus; Male; MAP Kinase Signaling System; Mice; Mice, Transgenic; Necrosis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Phosphorylation; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteinuria; Quinazolines; Rats; Rats, Sprague-Dawley

2004